Veradigm INC 8-K filings

Veradigm Inc. has extended its Stockholder Agreement with Charles and Jessica Myers, maintaining board observer status through December 31, 2026.

Veradigm Inc. has entered into a consulting agreement with Leland Westerfield and Wilcox Capital LLC to provide strategic financial advisory services through March 31, 2027.

Veradigm Inc. announced the filing of its Annual Reports on Form 10-K for fiscal years 2023 and 2024, marking a significant step towards regaining current SEC filing status.

Veradigm Inc. announced the appointment of Christian Greyenbuhl as its new Chief Financial Officer, effective May 11, 2026, or later, as the company works to become current with its SEC filings.

The SEC has concluded its investigation into Veradigm Inc. and its former executives, stating no enforcement action will be recommended.

Veradigm Inc. has extended its Stockholder Rights Plan, also known as a 'poison pill,' until December 31, 2026, citing ongoing risks and the need to protect shareholder value.

Veradigm Inc. has extended its Stockholder Agreement with Charles Myers, continuing his role as a Board observer until at least July 26, 2026, citing his valuable contributions.

Veradigm Inc. announced the extension of Interim CFO Leland Westerfield's employment through June 30, 2026, while a search for a permanent CFO is underway.

Veradigm Inc. announced preliminary Q2 2025 financial results, including a slight revenue decline, significant debt reduction, and reaffirmed its fiscal year 2025 outlook.

Veradigm Inc. announced the repurchase of approximately $44 million in principal amount of its 0.875% Convertible Senior Notes due 2027 for a total consideration of approximately $50 million.

Veradigm Inc. has extended its Stockholder Rights Plan to February 20, 2026, and increased the beneficial ownership trigger from 10% to 20% to protect shareholder value amidst ongoing financial reporting remediation.

Veradigm Inc. announces the appointment of Donald Trigg, a seasoned healthcare technology executive, as its new Chief Executive Officer and Board member, effective September 2, 2025.

Veradigm Inc. announced the formation of an Interim Office of the Chief Executive Officer following the departure of its interim CEO and extended a key stockholder agreement.

Veradigm Inc. has repurchased approximately $180 million of its 0.875% Convertible Senior Notes due 2027 after holders exercised their repurchase rights, leaving $44 million outstanding.

Veradigm Inc. announced preliminary unaudited financial results for Q1 2025, including revenue estimates and cash positions, while also detailing a new $100 million debt financing and reaffirming its 2025 fiscal year outlook, despite expecting to become current on SEC filings only in 2026.

Veradigm Inc. and Veradigm LLC have entered into a new $100 million senior secured term loan credit facility, with proceeds earmarked for repurchasing 2027 Convertible Senior Notes and general corporate use, featuring a PIK interest option until mid-2027.

Veradigm Inc. amends its 2024 Stock Incentive Plan, increasing the share pool by 6 million to attract and retain key personnel.

Veradigm Inc. announces the departure of Interim CEO Thomas Langan effective July 31, 2025, and the extension of Interim CFO Leland Westerfield's employment through December 31, 2025.

Veradigm Inc. dismisses Grant Thornton LLP as its independent auditor and engages BDO USA, P.C., effective immediately.

Veradigm Inc. amends its previous 8-K filing to announce the appointment of Jonathan Sacks to the Nominating and Governance Committee, effective immediately on April 10, 2025.

Veradigm announces updated financial estimates for 2023 and 2024, provides an outlook for 2025, and reports the filing of its restated 2022 Form 10-K.

Veradigm Inc. amends its previous 8-K filing to announce the appointment of Vinit K. Asar as Chair of the Nominating and Governance Committee and Louis Silverman to the Compensation Committee, effective immediately.

Veradigm Inc. appoints Jonathan Sacks and Bruce Felt as new independent directors and announces Lou Silverman will succeed Greg Garrison as Chairman.

Veradigm Inc. has amended its Stockholder Rights Agreement for the fourth time, modifying definitions of 'Distribution Time' and 'Exempt Person'.

Veradigm Inc. reports that its financial statements for 2020 and prior interim periods can no longer be relied upon due to misstatements, and the company is working to restate its financials.

Veradigm Inc. and Kent Lake PR LLC have entered into a cooperation agreement, resulting in board expansion and the appointment of two new independent directors.

Veradigm extends its Stockholder Rights Plan to August 20, 2025, and updates the exercise price to $32.00 to protect against potential creeping acquisitions.

Veradigm announces the resignation of a board member due to health reasons, the conclusion of its strategic alternatives review without a sale, and the commencement of an operational review to improve performance.

Veradigm Inc. reported that no holders of its 0.875% Convertible Senior Notes due 2027 elected to exercise their biannual repurchase rights on January 1, 2025, leaving all notes outstanding.

Veradigm Inc. has extended the contract of its Interim Chief Financial Officer, Leland Westerfield, through June 30, 2025.